Product image of Monopex (Dexamethasone Phosphate) supplied by GNH India

Monopex

Active Ingredient:
Dexamethasone Phosphate
Origin:
EU

Monopex (Dexamethasone Phosphate)

Dexamethasone phosphate, the active ingredient in Monopex, is a glucocorticoid presented as a sterile ophthalmic solution for ocular use. It reduces inflammation and immune responses in the eye, helping manage post‑operative inflammation, uveitis, and allergic conjunctivitis.

GNH India supplies Monopex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable sourcing for eye care professionals across multiple regions. Monopex is shipped under controlled conditions to maintain sterility and potency.

Manufacturer / TM Owner

Laboratoires Thea

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Monopex, a glucocorticoid ophthalmic solution, is used to treat inflammatory conditions of the eye.

  • Post‑operative ocular inflammation: reduces swelling, pain and redness after eye surgery.
  • Uveitis: suppresses intra‑ocular inflammation and helps preserve visual acuity.
  • Allergic conjunctivitis: alleviates itching, redness and tearing caused by allergic reactions.

How It Works

  • Dexamethasone phosphate is a pro‑drug that, after ocular administration, is converted to dexamethasone. The active molecule binds intracellular glucocorticoid receptors, and the resulting complex translocates to the nucleus where it modulates gene transcription. This suppresses pro‑inflammatory cytokine production, decreases leukocyte migration, and stabilises lysosomal membranes, producing anti‑inflammatory and immunosuppressive effects in ocular tissues.

Side Effects

Ocular administration of dexamethasone phosphate may be associated with a range of adverse reactions.

Common Side Effects

  • Increased intraocular pressure: transient rise that may require monitoring.
  • Blurred vision: temporary visual disturbance after instillation.
  • Eye irritation or burning sensation: mild discomfort at the application site.
  • Tearing or excessive lacrimation.
  • Conjunctival hyperemia: mild redness of the eye.

Serious or Rare Side Effects

  • Cataract formation: accelerated lens opacity with prolonged use.
  • Secondary ocular infection: bacterial or fungal infection due to immunosuppression.
  • Severe allergic reaction: swelling, erythema, or anaphylaxis.
  • Glaucoma: sustained elevation of intraocular pressure.
  • Retinal detachment: rare but vision‑threatening event.
  • Systemic adrenal suppression: unlikely but possible with extensive use.

Precautions & Warnings

Before prescribing Monopex, clinicians should consider several precautionary measures.

  • Screen for glaucoma: assess intraocular pressure before and during therapy.
  • Avoid in viral ocular infections: steroids may exacerbate viral replication.
  • Use with caution in diabetic patients: steroids can affect blood glucose control.
  • Monitor for cataract development during prolonged therapy.
  • Store at room temperature below 25°C: keep in the original container, protect from light and moisture.

Avoid Interactions

Dexamethasone phosphate can interact with other ophthalmic or systemic agents.

Major Interactions (Avoid)

  • Systemic corticosteroids: additive systemic glucocorticoid effects may increase risk of adrenal suppression.
  • Anticholinergic eye drops: may reduce the anti‑inflammatory efficacy of the steroid.
  • NSAID eye drops: combined use can increase risk of corneal melting.

Moderate Interactions (Monitor Closely)

  • Antiviral eye medications: concurrent use may require monitoring for infection progression.
  • Beta‑blocker eye drops: potential additive effect on intraocular pressure.
  • Cyclosporine eye drops: may alter local immunosuppressive balance and require observation.

Frequently Asked Questions

Monopex is an ophthalmic preparation containing dexamethasone phosphate. It is prescribed to reduce inflammation and immune activity in the eye, specifically for post‑operative ocular inflammation, uveitis, and allergic conjunctivitis.

After instillation, dexamethasone phosphate is converted to dexamethasone, which binds glucocorticoid receptors inside ocular cells. This complex alters gene expression, suppressing inflammatory cytokines, reducing leukocyte infiltration, and stabilising cellular membranes, thereby decreasing swelling and irritation in the eye.

The dosage regimen for Monopex is determined by the prescribing ophthalmologist based on the specific condition, severity, and patient response. The prescriber will provide detailed instructions on the number of drops, frequency, and duration of therapy.

Safety data for dexamethasone phosphate in pregnancy and lactation are limited. The product is classified as pregnancy category unknown, so clinicians must weigh potential benefits against possible risks and consider alternative therapies when appropriate.

To request Monopex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Monopex delivers dexamethasone phosphate, a potent glucocorticoid with rapid ocular penetration. Compared with weaker steroids such as loteprednol, it may achieve faster inflammation control, but it also carries a higher risk of intraocular pressure rise and cataract formation, requiring careful monitoring.

Monopex should be stored at room temperature below 25 °C, in its original sealed container. Protect the product from direct light, moisture and extreme temperatures. Do not freeze. Once opened, follow the label’s recommended period‑after‑opening to maintain sterility.

Monopex is applied as eye drops. The patient tilts the head back, pulls down the lower eyelid to form a pocket, and instills the prescribed number of drops without touching the tip to the eye or surrounding tissues. Hands should be washed before use.

Serious risks include a sustained increase in intraocular pressure leading to glaucoma, accelerated cataract formation, secondary ocular infections, and rare systemic effects such as adrenal suppression. Patients should be advised to report persistent vision changes, eye pain, or signs of infection promptly.

Monopex is contraindicated in patients with known hypersensitivity to dexamethasone phosphate or any component of the formulation. It should also be avoided in active viral ocular infections (e.g., herpes simplex keratitis) and in individuals with uncontrolled glaucoma unless closely monitored.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dexamethasone Phosphate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT